Business
Imaginostics Receives Siemens Healthineers Letter of Support as Companies Advance Quantitative MRI Dialogue
ORLANDO, Fla., March 20, 2026--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers.
About this update from Siemens Healthineers Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3450,"height":876,"url":"https://media.zenfs.com/en/business-wire.com/685b605f99e449048cde180c0fd87708"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KRjKdw6rFXOIWhRNxCD_2Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NA--/https://media.zenfs.com/en/business-wire.com/685b605f99e449048cde180c0fd87708","width":960,"height":244},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/MJhlvpVmoOjGL_jL0AeSuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02MTA-/https://media.zenfs.com/en/business-wire.com/685b605f99e449048cde180c0fd87708","width":1200,"height":305}},"lazy":false},{"type":"text","content":"ORLANDO, Fla., March 20, 2026--(BUSINESS WIRE)--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers.","length":278,"tagName":"p"},{"type":"text","content":"As part of these discussions, Imaginostics and Siemens Healthineers intend to continue dialogue concerning potential technical and commercial pathways for Imaginostics’ envisioned ImagiView™ and ImagiSight™ offerings and their potential applications for Siemens Healthineers MAGNETOM MRI systems.","length":296,"tagName":"p"},{"type":"text","content":""Quantitative MRI and imaging biomarkers have the potential to make imaging more objective, reproducible, and clinically actionable," said Dr. Codi Gharagouzloo, Scientific Founder & CSO. "This Letter of Support marks an important milestone for Imaginostics, and we look forward to continuing the technical and commercial dialogue with Siemens Healthineers," added Valerie Gharagouzloo, Co-Founder and CEO.","length":430,"tagName":"p"},{"type":"text","content":"The companies plan to continue evaluating potential opportunities within their respective technical, development, regulatory, and commercial frameworks. Any future collaboration or commercial activity would remain subject to further discussions, internal approvals, and definitive agreements.","length":292,"tagName":"p"},{"type":"text","content":"About Imaginostics","length":18,"tagName":"p"},{"type":"text","content":"Imaginostics is building vascular intelligence from t...